On September 28th, China Food and Drug Administration (CFDA) issued seven new medical device industry standards. Industry standards and scope of application are shown in the table.
NO. | Standard Name | Scope of Application |
YY/T 0661—2017 | Surgical implants Semi-crystalline poly (lactide) polymers and copolymers resins | It is suitable for the primary semi-crystalline poly (L-lactide) or poly (D- lactide) polymer resins for surgical implants, and is also suitable for the semi crystalline resins, which are copolymerization of L-lactide with other bio-absorbable monomers. It isn’t suitable for packaged, sterilized finished implants made from these materials. This standard replaces YY/T 0661-2008 |
YY/T 1141—2017 | General specification for Bone chisel | It is suitable for orthopedic surgical instruments. This standard replaces YY/T 91141—1999,YY 91071—1999,YY 91072—1999 and YY 91073—1999. |
YY/T 1426.3—2017 | Surgical implants abrasion of total knee prosthesis part 3: displacement-controlled wear tester load and displacement parameters and related test conditions | It is suitable for all knee prosthesis. |
YY/T 1552—2017 | Surgical implants Measuring method of open-circuit potential for long-term corrosion of metallic implant materials and medical devices | It is suitable for metal materials with corrosion resistant passivation film. |
YY/T 1553—2017 | Cardiovascular Implant Heart Occlusion device | It is suitable for cardiac occluder, which is used for the treatment of heart defects and other diseases by Catheter implantation, and suitable for conveying system which can be used as part of the heart sealing device. |
YY/T 1558.3—2017 | Surgical implants calcium phosphate part 3: hydroxyapatite and β- tricalcium phosphate bone substitutes | It is not suitable for other bone filling materials containing cell bone filler, calcium phosphate bone cement or not containing hydroxyapatite and β-tricalcium phosphate. |
YY/T 1567—2017 | Technical requirements and test methods for female condoms |